enGene Holdings Inc.

ENGN · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.5B · 82 employees
61
SEC Filings
$1.78
Close 2026-06-01
82
Employees

Business Summary

Competition for additional information. The genetic medicine field is relatively new and evolving rapidly. Because of our limited technical, financial and human resources, we are focusing our research and development efforts on detalimogene, as well as further development of our genetic medicine platform and other product candidates we may develop. As a result, we may forego or delay pursuit of other genetic medicine technologies or other therapeutic product candidates that provide significant a...

Latest Stock Quote

ENGN 2026-06-01 $1.78 O:$1.84 H:$1.85 L:$1.76 Vol:1.0M VWAP:$1.8158
origin leaf: ece02b8c8b7759a3e3fa5bb7979c16b14100ccba0373cb3d4f67336003160459

Next Earnings

Q2 FY2026 — expected 2026-09-12

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-12-222025-10-310001193125-25-328743EDGAR107K words
2024-12-192024-10-310000950170-24-138472EDGAR—
2024-01-292023-10-310000950170-24-008125EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-03-092026-01-310001193125-26-097541EDGAR24K words
2025-09-112025-07-310000950170-25-114224EDGAR—
2025-06-122025-04-300000950170-25-085143EDGAR—
2025-03-102025-01-310000950170-25-036281EDGAR—
2024-09-102024-07-310000950170-24-105180EDGAR—
2024-06-142024-04-300000950170-24-073330EDGAR—
2024-03-112024-01-310000950170-24-029413EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-090001193125-26-097546EDGAR26K words
2026-03-090001193125-26-097534EDGAR—
2026-01-210001193125-26-017945EDGAR—
2026-01-210001193125-26-017226EDGAR—
2025-12-220001193125-25-328706EDGAR—
2025-11-140001193125-25-283182EDGAR—
2025-11-120001193125-25-275722EDGAR—
2025-10-020001193125-25-228351EDGAR—
2025-09-300001193125-25-224053EDGAR—
2025-09-110000950170-25-114220EDGAR—

61 total filings indexed. 41 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001980845
TickerENGN
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedZ4
Websitehttps://www.engene.com
Listed2023-11-01

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: e1f590c026a96e0a783e00381deea5970ee83a829f4cc213c3c47a3368a0e81d
parent: b62ef4b64873bfad8a9804eacfad7a1a87b8199dbd45770834367bd3b0153351
content hash: 5673166c1e557ead144dd05f72eaf5d0e169ceb2747ecae1f2fee8cf838208cf
signed: 2026-06-03T12:00:58.595Z
sources: 11 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf